83 related articles for article (PubMed ID: 21849809)
1. Identification of transmembrane protein in prostate cancer by the Escherichia coli ampicillin secretion trap: expression of CDON is involved in tumor cell growth and invasion.
Hayashi T; Oue N; Sakamoto N; Anami K; Oo HZ; Sentani K; Ohara S; Teishima J; Matsubara A; Yasui W
Pathobiology; 2011; 78(5):277-84. PubMed ID: 21849809
[TBL] [Abstract][Full Text] [Related]
2. The search for secreted proteins in prostate cancer by the Escherichia coli ampicillin secretion trap: expression of NBL1 is highly restricted to the prostate and is related to cancer progression.
Hayashi T; Sentani K; Oue N; Ohara S; Teishima J; Anami K; Sakamoto N; Matsubara A; Yasui W
Pathobiology; 2013; 80(2):60-9. PubMed ID: 22948749
[TBL] [Abstract][Full Text] [Related]
3. High expression of a new marker PCA-1 in human prostate carcinoma.
Konishi N; Nakamura M; Ishida E; Shimada K; Mitsui E; Yoshikawa R; Yamamoto H; Tsujikawa K
Clin Cancer Res; 2005 Jul; 11(14):5090-7. PubMed ID: 16033822
[TBL] [Abstract][Full Text] [Related]
4. Selective identification of secreted and transmembrane breast cancer markers using Escherichia coli ampicillin secretion trap.
Ferguson DA; Muenster MR; Zang Q; Spencer JA; Schageman JJ; Lian Y; Garner HR; Gaynor RB; Huff JW; Pertsemlidis A; Ashfaq R; Schorge J; Becerra C; Williams NS; Graff JM
Cancer Res; 2005 Sep; 65(18):8209-17. PubMed ID: 16166296
[TBL] [Abstract][Full Text] [Related]
5. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.
Calvo A; Xiao N; Kang J; Best CJ; Leiva I; Emmert-Buck MR; Jorcyk C; Green JE
Cancer Res; 2002 Sep; 62(18):5325-35. PubMed ID: 12235003
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profile of prostate cancer cell lines: effect of nerve growth factor treatment.
Sigala S; Bodei S; Missale C; Zani D; Simeone C; Cunico SC; Spano PF
Mol Cell Endocrinol; 2008 Mar; 284(1-2):11-20. PubMed ID: 18280641
[TBL] [Abstract][Full Text] [Related]
7. Identification of PRL1 as a novel diagnostic and therapeutic target for castration-resistant prostate cancer by the Escherichia coli ampicillin secretion trap (CAST) method.
Shinmei S; Sentani K; Hayashi T; Sakamoto N; Goto K; Oo HZ; Naito Y; Teishima J; Matsubara A; Oue N; Kuniyasu H; Yasui W
Urol Oncol; 2014 Aug; 32(6):769-78. PubMed ID: 24968948
[TBL] [Abstract][Full Text] [Related]
8. CCR2 expression correlates with prostate cancer progression.
Lu Y; Cai Z; Xiao G; Liu Y; Keller ET; Yao Z; Zhang J
J Cell Biochem; 2007 Jun; 101(3):676-85. PubMed ID: 17216598
[TBL] [Abstract][Full Text] [Related]
9. Bystin in perineural invasion of prostate cancer.
Ayala GE; Dai H; Li R; Ittmann M; Thompson TC; Rowley D; Wheeler TM
Prostate; 2006 Feb; 66(3):266-72. PubMed ID: 16245277
[TBL] [Abstract][Full Text] [Related]
10. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.
Navone NM; Rodriquez-Vargas MC; Benedict WF; Troncoso P; McDonnell TJ; Zhou JH; Luthra R; Logothetis CJ
Clin Cancer Res; 2000 Mar; 6(3):1190-7. PubMed ID: 10741751
[TBL] [Abstract][Full Text] [Related]
11. The role of zinc transporter ZIP4 in prostate carcinoma.
Chen QG; Zhang Z; Yang Q; Shan GY; Yu XY; Kong CZ
Urol Oncol; 2012; 30(6):906-11. PubMed ID: 21803616
[TBL] [Abstract][Full Text] [Related]
12. Expression of CCL5 (RANTES) and CCR5 in prostate cancer.
Vaday GG; Peehl DM; Kadam PA; Lawrence DM
Prostate; 2006 Feb; 66(2):124-34. PubMed ID: 16161154
[TBL] [Abstract][Full Text] [Related]
13. Systematic search for gastric cancer-specific genes based on SAGE data: melanoma inhibitory activity and matrix metalloproteinase-10 are novel prognostic factors in patients with gastric cancer.
Aung PP; Oue N; Mitani Y; Nakayama H; Yoshida K; Noguchi T; Bosserhoff AK; Yasui W
Oncogene; 2006 Apr; 25(17):2546-57. PubMed ID: 16331256
[TBL] [Abstract][Full Text] [Related]
14. Identification of metastasis-associated genes in prostate cancer by genetic profiling of human prostate cancer cell lines.
Trojan L; Schaaf A; Steidler A; Haak M; Thalmann G; Knoll T; Gretz N; Alken P; Michel MS
Anticancer Res; 2005; 25(1A):183-91. PubMed ID: 15816537
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers.
Sun A; Tawfik O; Gayed B; Thrasher JB; Hoestje S; Li C; Li B
Prostate; 2007 Feb; 67(2):203-13. PubMed ID: 17075831
[TBL] [Abstract][Full Text] [Related]
16. Multiple tumor marker analyses (PSA, hK2, PSCA, trp-p8) in primary prostate cancers using quantitative RT-PCR.
Fuessel S; Sickert D; Meye A; Klenk U; Schmidt U; Schmitz M; Rost AK; Weigle B; Kiessling A; Wirth MP
Int J Oncol; 2003 Jul; 23(1):221-8. PubMed ID: 12792797
[TBL] [Abstract][Full Text] [Related]
17. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues: implications for prostate carcinogenesis and progression of prostate cancer.
Zhigang Z; Wenlv S
Jpn J Clin Oncol; 2004 Jul; 34(7):414-9. PubMed ID: 15342669
[TBL] [Abstract][Full Text] [Related]
18. Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development.
Ishiguro H; Nakaigawa N; Miyoshi Y; Fujinami K; Kubota Y; Uemura H
Prostate; 2005 Jun; 64(1):92-100. PubMed ID: 15666359
[TBL] [Abstract][Full Text] [Related]
19. [Overexpression of human tumor metastasis-related gene TMSG-1 suppresses cell proliferation and invasion of a highly metastatic prostate cancer cell line PC-3M-1E8 in vitro].
Su J; You JF; Wang JL; Cui XL; Fang WG; Zheng J
Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):404-7. PubMed ID: 19024511
[TBL] [Abstract][Full Text] [Related]
20. A novel human prostate-specific gene-1 (HPG-1): molecular cloning, sequencing, and its potential involvement in prostate carcinogenesis.
Herness EA; Naz RK
Cancer Res; 2003 Jan; 63(2):329-36. PubMed ID: 12543784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
